CLDX icon

Celldex Therapeutics

182 hedge funds and large institutions have $2.58B invested in Celldex Therapeutics in 2024 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 81 increasing their positions, 49 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding in top 10

Funds holding in top 10:

less ownership

Funds ownership:

less funds holding

Funds holding:

11% less capital invested

Capital invested by funds: $2.91B → $2.58B (-$333M)

33% less first-time investments, than exits

New positions opened: 24 | Existing positions closed: 36

80% less call options, than puts

Call options by funds: $3.39M | Put options by funds: $17M

Holders
182
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$3.39M
Puts
$17M
Net Calls
Net Calls Change

Top Sellers

1 -$70.2M
2 -$27.3M
3 -$11.9M
4
AG
Artal Group
Luxembourg
-$10.6M
5
Renaissance Technologies
Renaissance Technologies
New York
-$9.98M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$4.8M
52
$4.7M
53
$4.64M
54
$4.46M
55
$4.43M
56
$4.42M
57
$4.38M
58
$4.23M
59
$4.16M
60
$3.57M
61
$3.57M
62
$3.37M
63
$3.16M
64
$2.88M
65
$2.8M
66
$2.79M
67
$2.7M
68
$2.43M
69
$2.16M
70
$2.12M
71
$2.09M
72
$2.01M
73
$2M
74
$1.93M
75
$1.93M